PRO MEDICUS LIMITED — AGM Information 2009

Nov 23, 2009

==> picture [781 x 271] intentionally omitted <==

----- Start of picture text -----

Transformed and ready to go....
----- End of picture text -----

Annual General Meeting November 24[th] 2009

Australia’s Leading HealthCare IT Company

==> picture [781 x 271] intentionally omitted <==

----- Start of picture text -----

PROMEDICUS
----- End of picture text -----

• Mel Ward - Chairman

Board Members

==> picture [187 x 181] intentionally omitted <==

==> picture [187 x 243] intentionally omitted <==

• Mel Ward – Chairman

• David Chambers – CEO & Managing Director

• � Sam Hupert – Deputy Chairman & Executive Director

• Anthony Hall – Executive Director

• Peter Jonson – Non-Executive Director

• � Peter Kempen – Non-Executive Director

==> picture [776 x 27] intentionally omitted <==

Officers

==> picture [187 x 181] intentionally omitted <==

==> picture [187 x 243] intentionally omitted <==

� Danny Tauber – Chief Operating Officer � Clayton Hatch – Finance Manager

• Company Secretary

• Stuart Painter – Ernst and Young Auditor

In absentia:

� Malte Westerhoff – Chief Technology Officer (Visage - Germany)

• Mike Tefft – National Business Manager (Visage - USA)

==> picture [776 x 27] intentionally omitted <==

Pro Medicus – In Perspective

==> picture [183 x 181] intentionally omitted <==

==> picture [183 x 243] intentionally omitted <==

• 2007/08 –Sustained profit growth and optimism re acquisition opportunity.

• 2008/09 – A time of change facing the global financial crisis, a major acquisition , and changes with overseas partner.

• 2009/10 – A time of transition to a challenging but potentially much stronger future.

==> picture [776 x 27] intentionally omitted <==

Pro Medicus – 2007/08

==> picture [187 x 181] intentionally omitted <==

==> picture [187 x 243] intentionally omitted <==

• What were our messages last year?

• World wide GFC started --- fear of recession

• Mature Australian market --- need to go off-shore

• US key to our future growth

• New AGFA agreement but standalone PME in US

• Search on for complementary acquisition

• Economic future looked tough with deferred capital spending and increased competition

==> picture [776 x 27] intentionally omitted <==

2008/09 – A Tough Year of Change

==> picture [187 x 181] intentionally omitted <==

==> picture [187 x 243] intentionally omitted <==

• GFC – Dramatic impact on last 3 quarters of year

• Downturn of health IT spending in US

• Contraction in Aust market due to:

• GFC effect

• M a ur t it y o f di g it a mar l k e t

• • Increased competition with aggressive prices

• Costs of establishing standalone company in US

• Changes to the Agfa relationship in the U.S. market and our loss of income from AGFA contract

• • Acquisition of Visage Imaging was standout opportunity highlight

==> picture [776 x 27] intentionally omitted <==

Pro Medicus – 2008/09 Highlights

• Revenue, including acquisition, up 1.4% to $15.62M

• NPAT down 28.4% to $5.68M

• Fi i i li i h fi t as a h f ll en rst t me s nce st ng t at pro

• • Acquisition of Visage is transformational

• • Acquisition funded from cash

• Balance Sheet still strong – no debt and $5.6M cash as at 30[th] June.

==> picture [776 x 27] intentionally omitted <==

Pro Medicus – 2008/09 Highlights

==> picture [217 x 181] intentionally omitted <==

==> picture [217 x 243] intentionally omitted <==

• Final dividend of 2c per share fully franked following interim dividend of 1.5c

• Significant reduction of net margin from acquisition and effect of competition in both US and Australia

• Service revenues and Promedicus.net revenue held up well

==> picture [776 x 27] intentionally omitted <==

Pro Medicus – Visage Imaging

==> picture [187 x 181] intentionally omitted <==

==> picture [187 x 243] intentionally omitted <==

• The long search for a complementary off-shore partner has been reported for some years

• Cash was held in reserve for this purpose

• The right partner was found in late 2008 in Visage Imaging

• GFC downturn in asset prices assisted buy

• CEO will demonstrate the exciting complementary products from this company and illustrate the value from an integrated set of PME and Visage offerings

==> picture [776 x 27] intentionally omitted <==

Promedicus – Visage

• Visage was initially loss making (PME funding) but back to break even

• Growing revenue from sales in all three markets

• Other revenue streams from Visage (OEM, Amira) are profitable

• W e t r ade as Vi Im in in N o r t h Am e ri ca a n d E u r to sage ag g ope

• gain branding advantage

==> picture [776 x 27] intentionally omitted <==

Pro Medicus – PME/Visage Integration

==> picture [200 x 181] intentionally omitted <==

==> picture [200 x 243] intentionally omitted <==

• Visage is Berlin based and has a very strong R&D capability.

• Integration of R&D: Melbourne PME team with Berlin Visage team, going well with full alignment on product strategy

• PME M e lb ourne o ec ti ve o f h i t t ll bj av ng a o a y

• modernized RIS and Practice Management System by mid 2010

• The combined capability will be demonstrated first at the RSNA major annual conference/exhibition in Chicago this month

==> picture [776 x 27] intentionally omitted <==

Pro Medicus – Key Issues

• Successfully complete integrated product development to the 2010 schedule

• Extend upon brand recognition and make o p timal im p act at RSNA ( November 2009 )

• Well balanced R&D teams in Melb and Berlin,

• Must accelerate sales and marketing skills

• Opportunity pipeline is good but must close sales and build momentum

==> picture [776 x 27] intentionally omitted <==

Looking Forward --- 2009/10

• This is a major transition year

• World wide there are still volatile and uncertain conditions

• Share markets are still far below their pre-crisis levels

• With PME and Visage combined products we have achieved some key reference sites already in the US and Australia and Europe

• Can now address the hospital market as well as the private radiology practices

• North America and Europe are key to our future growth

==> picture [776 x 27] intentionally omitted <==

2009/10 Outlook

==> picture [195 x 181] intentionally omitted <==

==> picture [195 x 243] intentionally omitted <==

• Continuing investment in product development and integration

• Continued investment in sales team development in US and Australia

• A slow start in 1[st] Quarter but momentum expected to b u ild i n o t th e 2[nd] h a lf

• • Profit outcome expected to be approximately the same as last year

• Expanded PME remains healthy and positive, and well placed to realise value from a leading edge integrated medical system

==> picture [776 x 27] intentionally omitted <==

Pro Medicus -- Final Comments

==> picture [187 x 181] intentionally omitted <==

==> picture [187 x 243] intentionally omitted <==

• Continue to move to refresh Board for the future

• My thanks to Directors for their strong contribution

• W e come o our new uropean an l t E d N or th American staff who have joined the PME family

• • Thanks to our management and staff for their innovative creativity and hard work

• • This year will be tough but a strong future beckons

==> picture [776 x 27] intentionally omitted <==

==> picture [781 x 271] intentionally omitted <==

----- Start of picture text -----

PROMEDICUS
----- End of picture text -----

• David Chambers – CEO & Managing Director

The ‘new’ Promedicus …evolution of a global strategy

==> picture [521 x 262] intentionally omitted <==

----- Start of picture text -----

M&A R&D
Amira Visage 3D RIS/PMS E:Health
.net
2D/3D/4D RIS Ver 7
Life Sciences
Healthcare
3D tools Visage 7
.
PACS/RIS/3D net/portals
----- End of picture text -----

• Acquisition of Visage Imaging (January 2009)

• A comprehensive Healthcare and Life Science portfolio

• Integration on track

==> picture [95 x 23] intentionally omitted <==

Visage Imaging[®] So who is Visage Imaging?

==> picture [222 x 153] intentionally omitted <==

==> picture [549 x 147] intentionally omitted <==

==> picture [549 x 73] intentionally omitted <==

==> picture [222 x 91] intentionally omitted <==

• Clinical Imaging Products: 3D Advanced Visualization software

• Visualization Products for other Life Sciences: Amira[®]

• Direct Sales and OEM Business

==> picture [776 x 27] intentionally omitted <==

Opportunity to bring together all the pieces for a best practice end to end solution

PME provide the RIS (Practice Management) & E:Health

Visage provide the PACS (2D) and 3D advanced visualisation software

In combination, we have developed the most comprehensive “end to end” single vendor PACS/RIS solution available Global Markets

==> picture [776 x 27] intentionally omitted <==

Technology Synergies

==> picture [238 x 175] intentionally omitted <==

==> picture [238 x 243] intentionally omitted <==

• Integration of two products (RIS/PACS) realizes vision of becoming true single vendor solution .

• New products and development skills in Berlin

• ‘

• • Expand the reach of information through use of thin client’

• Move ahead of technology wave from 2D to 3D/4D

• Adaptable to different buying models e.g. ASP (pay as you go)

• First company with ability to deliver 3D images to GP and specialists in either Windows or MAC OS.

==> picture [776 x 27] intentionally omitted <==

Business Synergies

==> picture [245 x 175] intentionally omitted <==

==> picture [245 x 237] intentionally omitted <==

• Expanded installed base and local understanding of markets (e.g. US, Europe) provides basis for growth

• Up-selling opportunities for local Australian business

• Expand target audience to public hospitals

• Added and different channel models e.g. OEM’s, web store

• Standardizes IT infrastructure, finance, accounts and customer support via use of Netsuite

==> picture [776 x 27] intentionally omitted <==

Pro Medicus, now truly global…

A Full Suite of Enterprise PACS/RIS/Visualization and E:Health Business Software Solutions

• 70 employees, in four centers (US, Germany and Australia)

• ISO 9001 + 13485 certified, FDA/CE/CAMCAS cleared medical products

• Turnover ~A$23M, Market Capitalization ~A$75 M

==> picture [781 x 271] intentionally omitted <==

----- Start of picture text -----

Berlin
German
Boston, MA
USA
San Diego, CA
USA
Melbourne
Australia
----- End of picture text -----

Synergies create a Global Strategy

==> picture [781 x 440] intentionally omitted <==

----- Start of picture text -----

3D
‘PACS/RIS’
Appliance
Visage 7 Sales
Visage 7
PACS
Enterprise
PME
OEM’s
RIS/PMS
E:Health
Amira
----- End of picture text -----

Major Highlights 2008/2009

==> picture [200 x 181] intentionally omitted <==

==> picture [200 x 243] intentionally omitted <==

• Acquisition in January 2009

• Visage integration has been very successful

• Sales momentum is increasing in US and Europe.

• Several deals e.g. Hamburg, Connecticut in 1[st] six months

• Attended several major conferences with positive feedback e.g. U.K. and European radiology congresses.

• New partnerships initiated e.g. Telegentis.

• 26,070 Doctors using Promedicus.net network, remains leading market position.

==> picture [776 x 27] intentionally omitted <==

Medical Imaging Market Data explosion poses big challenges to radiology

• Typical CT Exam:

• • 1995 – 20 Images per CT Exam

• • 2000 – 100 Images per CT Exam

• • 2009 – 2,000 Images per CT Exam

==> picture [781 x 271] intentionally omitted <==

How ‘Thin Client’ Make Life Easier

==> picture [231 x 181] intentionally omitted <==

==> picture [231 x 243] intentionally omitted <==

• Images do not move from where they are generated – incredibly network efficient

• Access to images, and use of all the tools when/where they are needed, irrespective of location, ima g e size or com p lexit y

• Flexibility to work from home or office

• Image access when doctors are on call

• Combines 2D with fast and easy 3D manipulation

==> picture [776 x 27] intentionally omitted <==

The Lake Imaging Solution Combines all Promedicus products

==> picture [781 x 445] intentionally omitted <==

----- Start of picture text -----

Ordering
Order Entry
Scheduling
Decision Support
Patient arrival
Business
Intelligence
RIS/PACS/3D
Reporting
Acquisition
Billing
Integrated
workflow
2D/3D/4D + Advanced Clinical
Applications
Notification &
Distribution
Clinical Data Access
Reporting &
For Decision Support
sign off
Lake Imaging confirms our strategy using Promedicus technologies
----- End of picture text -----

RSNA Ad Campaign – Visage 7

==> picture [79 x 35] intentionally omitted <==

==> picture [79 x 45] intentionally omitted <==

Now Apple MAC Compatible

==> picture [342 x 181] intentionally omitted <==

==> picture [342 x 243] intentionally omitted <==

==> picture [776 x 27] intentionally omitted <==

Visage 7…True Versatility.True Performance

• Visage 7 ‘unified viewer’ using thin client technology allows Radiologists to see images anywhere, in the fastest possible time

• Can be an Enterprise Viewer or incorporated in to end to end imaging centre solution (like Lake Imaging)

• Full 2D/3D/4D. Images do not move.

• Working hours will be more productive and efficient.

• Healthcare providers now empowered to prevent or diagnose disease earlier, improving quality of life for patients while reducing costs

==> picture [776 x 27] intentionally omitted <==

Quotes from our recent clients…

Enterprise Viewer Setting (in Hospital)

Distributed Viewer Setting (in Imaging Centre)

• “There are 3 important requirements that I consider when evaluating an enterprise server/thin client advanced visualization solution:

• 1) performance/scalability,

• “We wanted to step up to a 4th generation PACS and after an exhaustive search, identified Pro Medicus as having all the things we wanted in a fully integrated next generation PACS/RIS system.

• 2) fully featured functionality , and

• 3) seamless integration into existing PACS workflow and applications.

It continues our strong relationship with Pro Medicus with a decision that makes both business and clinical sense for us.

• Visage addresses these requirements impressively”

November 2009

This move puts us two years ahead of the other players”.

Paul J. Chang M.D., Medical Director, University of Chicago Hospitals

November 2009

John Livingstone, CEO Lake Imaging

==> picture [776 x 27] intentionally omitted <==

Amira - Smart Imaging in Life Sciences making sense of large volume data sets

Volumetric Analyis

==> picture [144 x 126] intentionally omitted <==

Blood Flow

==> picture [131 x 112] intentionally omitted <==

==> picture [177 x 150] intentionally omitted <==

Numerical Simulation

Anatomic Modelling

==> picture [138 x 133] intentionally omitted <==

==> picture [134 x 127] intentionally omitted <==

Drug Development / Molecular

==> picture [161 x 114] intentionally omitted <==

Virtual Reality

==> picture [95 x 23] intentionally omitted <==

Images: amira[®]

Investment in Future

==> picture [200 x 175] intentionally omitted <==

==> picture [200 x 243] intentionally omitted <==

• Investments in R&D bearing fruit with milestones met for new technology platform.

• Ongoing investment in new people and infrastructure.

• Under ins future b transitionin roducts to new p y g p

• technology platform.

• Increasing our presence and skills in North America.

• .

• Established a base in Europe

• We now have the foundations for future growth in local and overseas markets.

==> picture [776 x 27] intentionally omitted <==

We believe we have the right growth strategies for 2010

==> picture [781 x 404] intentionally omitted <==

----- Start of picture text -----

New sales
US and European
channels
expansion
Expanded Visage Imaging –
Promedicus
product portfolio continuing integration
New (RIS) Penetrate
technology platform hospital market
----- End of picture text -----

PROMEDICUS

==> picture [781 x 271] intentionally omitted <==

RESOLUTION OF SHAREHOLDERS

• Resolution 2 – To adopt the Remuneration Report (non binding)

FOR OPEN 21,881,759 346,312 96.96% 1.53%

AGAINST 339,967 1.51%

==> picture [776 x 27] intentionally omitted <==

RESOLUTION OF SHAREHOLDERS

• Resolution 3A – To elect as a Director Dr Sam Hupert

FOR OPEN 22,140,011 415,212 98.08% 1.84%

AGAINST 19,000 0.08%

==> picture [776 x 27] intentionally omitted <==

RESOLUTION OF SHAREHOLDERS

• Resolution 3B – To elect as a Director Mr Melvyn Ward

FOR OPEN 22,134,697 415,212 97.97% 1.84%

AGAINST 44,314 0.20%

==> picture [776 x 27] intentionally omitted <==